Cidofovir is an injectable antiviral medication belonging to the nucleotide analogue class, primarily utilized to treat cytomegalovirus (CMV) retinitis in patients with AIDS. To support the rigorous analytical… Read more

![Chemical structure of 1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1312776-50-3-1-S-3-Hydroxy-2-O-ethylphosphonomethoxypropylcytosine.png&w=3840&q=75)




![Chemical structure of Cidofovir Enantiomer (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate) (1133864)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FCidofovir-Enantiomer-1-R-3-Hydroxy-2-phosphonomethoxypropylcytosine-dihydrate-1133864.png&w=3840&q=75)
![Chemical structure of Cidofovir Related Compound B (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydro (1133886)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FCidofovir-Related-Compound-B-1-S-3-Hydroxy-2-OO-diethylphosphonomethoxypropylcytosine-hydro-1133886.png&w=3840&q=75)


Cidofovir is an injectable antiviral medication belonging to the nucleotide analogue class, primarily utilized to treat cytomegalovirus (CMV) retinitis in patients with AIDS. To support the rigorous analytical testing and quality control required for this active pharmaceutical ingredient, specialized reference standards are essential. This collection includes a comprehensive range of compounds, including pharmacopeial and non-pharmacopeial impurities, uracil analogs, brominated derivatives, and specific enantiomers. By utilizing stable isotope labelled standards and related compounds, pharmaceutical laboratories can perform accurate impurity profiling and validate complex analytical methods. These materials provide the necessary controls to monitor drug stability and detect trace-level degradation products, ensuring reliable performance throughout the development and manufacturing lifecycle of the pharmaceutical product.